Fig. 2

Identification of URGs-related molecular subtypes and differential analysis of immune microenvironment between subtypes. (A) Consensus clustering and (B) t-SNE analysis showing that AML patients were classified into two molecular subtypes named cluster A (n = 77) and cluster B (n = 55), respectively. (C) Heatmap showing the differential expression profiles of 22 URGs between the two molecular subtypes. (D) Survival outcomes, (E) TME scores, (F) immune cell infiltrations, (G) expression levels of immune check point genes and (H) TIDE scores were compared between the two molecular subtypes. *p < 0.05, **p < 0.01, *** p < 0.001, **** p < 0.0001.